Top news of the week: 24.06.2022.
Galapagos Dives Into Cell Therapy with CellPoint & AboundBio Acquisitions
Galapagos announced that it had acquired CellPoint and AboundBio in an all-cash transaction, greatly expanding its drug portfolio.
Regeneron Breaks Ground on $1.8B NY Expansion Project
Regeneron has broken ground on a $1.8 billion expansion of its Tarrytown, NY facilities that will add at least 1,000 new full-time jobs.
Biden Nominates First Woman and Person of Color to Serve as Science Advisor
U.S. President Joe Biden nominated Arati Prabhakar, Ph.D., to be his science advisor. If confirmed by the Senate, Prabhakar will become the first woman, first person of color and the first ...
Rapid, AI-Based, Genome Mapping Discovers Cancer Driving Mutations
Deep neural network system maps cancer-specific mutation rates, genome-wide, at kilobase-scale resolution, by rapidly scanning the genomes of cancer cells.
NYC Life Sciences Sector Poised for High-Growth Phase
According to a recent report, the New York City Metro area is home to 7% of the U.S. population but contains 10% of all U.S. biochemists and biophysicists and 12% of U.S. chemists.
Moderna, GSK, Sanofi, AstraZeneca and BioNTech Expand Global Ops
It's been a busy month for big biopharma companies looking to expand operations with Moderna, AstraZeneca, Sanofi and more are setting up new facilities internationally.
Can Olema Oncology Prevail Where Other SERDs have Recently Failed?
Olema president and CEO Sean Bohen spoke with BioSpace about why he believes his company's approach with a SERD and ER antagonist can successfully treat an advanced form of breast cancer.
15 leaders giving voice and visibility to the LGBTQ community in biopharma
I’ve gone back and forth on the message and tone of this intro — my thoughts fluctuating between steps on runs, during gas station stops on a road trip with fellow gay friends, mid-flight ...